bioAffinity Technologies Inc. (BIAFW)
bioAffinity Technologies Launches New Study To Expand Use ofCyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment
bioAffinity Technologies Launches New Study To Expand Use ofCyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak financial signals • Minimal market impact expected **Sentiment:** Neutral (50%) **Content type:** Financial